Initial results from first-in-human study of IPI-549, a tumor macrophage-targeting agent, combined with nivolumab in advanced solid tumors Meeting Abstract

  

Authors:	Sullivan, R. J.; Hong, D. S.; Tolcher, A. W.; Patnaik, A.; Shapiro, G.; Chmielowski, B.; Ribas, A.; Brail, L. H.; Roberts, J.; Lee, L.; O'Connell, B.; Kutok, J. L.; Mahabhashyam, S.; Ullmann, C. D.; Postow, M. A.; Wolchok, J. D.
Abstract Title:	Initial results from first-in-human study of IPI-549, a tumor macrophage-targeting agent, combined with nivolumab in advanced solid tumors
Meeting Title:	54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	36
Issue:	15 Suppl.
Meeting Dates:	2018 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2018-05-20
Start Page:	140s
Language:	English
ACCESSION:	WOS:000442916001387
DOI:	10.1200/JCO.2018.36.15_suppl.3013
PROVIDER:	wos
Notes:	Meeting Abstract: 3013 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169646